Your browser doesn't support javascript.
loading
Issues related to the approval of the R21/Matrix-M malaria vaccine for use in Nigeria and Ghana.
Dzi, Kevin T J.
Affiliation
  • Dzi KTJ; Département de la formation et recherche, Institut des humanités en médecine (IHM), Centre hospitalier universitaire vaudois et Universite de Lausanne, Lausanne, Switzerland.
Front Public Health ; 11: 1237011, 2023.
Article in En | MEDLINE | ID: mdl-37860804
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Malaria Vaccines / Malaria Limits: Humans Country/Region as subject: Africa Language: En Journal: Front Public Health Year: 2023 Document type: Article Affiliation country: Switzerland Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Malaria Vaccines / Malaria Limits: Humans Country/Region as subject: Africa Language: En Journal: Front Public Health Year: 2023 Document type: Article Affiliation country: Switzerland Country of publication: Switzerland